Axial Therapeutics announced that A. Stewart Campbell, Ph.D., chief executive officer, will participate in a panel titled “Placing Patients...

Read more

Axial Therapeutics announced that its scientific founder and California Institute of Technology (Caltech) Professor, Sarkis Mazmanian, Ph.D., will be...

Read more
By: Kairos Ventures On: February 14, 2022 In: Axial Therapeutics, Portfolio News

Axial Therapeutics announced the publication of preclinical research demonstrating that microbial metabolites produced by gut bacteria commonly found in...

Read more
By: Kairos Ventures On: February 14, 2022 In: Axial Therapeutics, Portfolio News

Axial Therapeutics announced the publication in Nature Medicine of full results from its Phase 1b/2a clinical trial of AB-2004....

Read more

Axial Therapeutics announced that management will participate in a fireside chat at the 2020 RBC Capital Markets Healthcare Private...

Read more

Axial Biotherapeutics announced a $440,000 grant from the Michael J. Fox Foundation for Parkinson’s Research to support its efforts...

Read more

Kairos Ventures portfolio company Axial Biotherapeutics announced the appointment of Dr. Gregory T. Bates as Senior Vice President of...

Read more
By: Kairos Ventures On: September 26, 2017 In: Axial Therapeutics, Portfolio News

We're excited to share that our portfolio company, Axial Biotherapeutics, has been selected as one of FierceBiotech's Fierce 15...

Read more

This month, Axial Biotherapeutics announced the appointment of leading experts in the Autism Spectrum Disorders (ASD) field to its...

Read more

Axial Biotherapeutics today announced the launch of the Company with a $19.15 million Series A round of financing. The...

Read more